Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer

(MedPage Today) -- Gene-guided treatment selection for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) failed to improve disease control versus random treatment selection in a small preliminary clinical trial. Personalized treatment...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news